And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept
The internal organ at risk volume (IRV) concept might improve toxicity profiles in stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC). We studied (1) clinical aspects in central vs. peripheral tumors, (2) the IRV concept in central tumors, (3) organ motion, and (4) ass...
Main Authors: | Felix-Nikolai Oschinka Jegor Habermann, Daniela Schmitt, Thomas Failing, David Alexander Ziegler, Jann Fischer, Laura Anna Fischer, Manuel Guhlich, Stephanie Bendrich, Olga Knaus, Tobias Raphael Overbeck, Hannes Treiber, Alexander von Hammerstein-Equord, Raphael Koch, Rami El Shafie, Stefan Rieken, Martin Leu, Leif Hendrik Dröge |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/1/231 |
Similar Items
-
Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes
by: Felix-Nikolai Oschinka Jegor Habermann, et al.
Published: (2022-02-01) -
Are liver contour and bone fusion comparable to fiducials for IGRT in liver SBRT?
by: C. de la Pinta, et al.
Published: (2023-09-01) -
How to Improve SBRT Outcomes in NSCLC: From Pre-Clinical Modeling to Successful Clinical Translation
by: Marina Milic, et al.
Published: (2022-03-01) -
The Effectiveness and Safety of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Oligoprogressive Breast Cancer: A Systematic Review
by: Bernie Yan, et al.
Published: (2023-07-01) -
LINAC-based SBRT in treating early-stage NSCLC patients—single institution experience and survival data analysis
by: Árpád Kovács, et al.
Published: (2024-02-01)